ID17875A - PHARMACEUTICAL COMPOSITION THAT CONTAINS 4-OXSOBUTANOIC ACID - Google Patents

PHARMACEUTICAL COMPOSITION THAT CONTAINS 4-OXSOBUTANOIC ACID

Info

Publication number
ID17875A
ID17875A IDP972848A ID972848A ID17875A ID 17875 A ID17875 A ID 17875A ID P972848 A IDP972848 A ID P972848A ID 972848 A ID972848 A ID 972848A ID 17875 A ID17875 A ID 17875A
Authority
ID
Indonesia
Prior art keywords
oxsobutanoic
acid
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
IDP972848A
Other languages
Indonesian (id)
Inventor
Gerard Moinet
Philippe Mayzeray
Liliane Doare
Micheline Kergoat
Didier Mesangeau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ID17875A publication Critical patent/ID17875A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/84Unsaturated compounds containing keto groups containing six membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDP972848A 1996-08-16 1997-08-14 PHARMACEUTICAL COMPOSITION THAT CONTAINS 4-OXSOBUTANOIC ACID ID17875A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9610254A FR2752422B1 (en) 1996-08-16 1996-08-16 PHARMACEUTICAL COMPOSITION CONTAINING 4-OXO-BUTANOIC ACIDS

Publications (1)

Publication Number Publication Date
ID17875A true ID17875A (en) 1998-02-05

Family

ID=9495089

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972848A ID17875A (en) 1996-08-16 1997-08-14 PHARMACEUTICAL COMPOSITION THAT CONTAINS 4-OXSOBUTANOIC ACID

Country Status (29)

Country Link
US (1) US6143787A (en)
EP (1) EP0925273B1 (en)
JP (1) JP3105545B2 (en)
KR (1) KR100488430B1 (en)
CN (1) CN1082370C (en)
AR (1) AR009251A1 (en)
AT (1) ATE208364T1 (en)
AU (1) AU725440B2 (en)
BR (1) BR9711315A (en)
CA (1) CA2263348C (en)
CY (1) CY2298B1 (en)
CZ (1) CZ294165B6 (en)
DE (1) DE69708130T2 (en)
DK (1) DK0925273T3 (en)
ES (1) ES2166098T3 (en)
FR (1) FR2752422B1 (en)
HU (1) HUP0004223A3 (en)
ID (1) ID17875A (en)
NO (1) NO312290B1 (en)
PL (1) PL187371B1 (en)
PT (1) PT925273E (en)
RU (1) RU2175966C2 (en)
SI (1) SI0925273T1 (en)
SK (1) SK283055B6 (en)
TR (1) TR199900329T2 (en)
TW (1) TW438764B (en)
UA (1) UA57031C2 (en)
WO (1) WO1998007681A1 (en)
ZA (1) ZA977327B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04318852A (en) * 1991-04-18 1992-11-10 Fujitsu Ltd Resist pattern forming method
MXPA03011558A (en) 2001-06-12 2004-03-26 Wellstat Therapeutics Corp COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS.
FR2832633B1 (en) * 2001-11-28 2004-09-24 Lipha PHARMACEUTICAL COMPOSITION COMPRISING A METFORMIN ASSOCIATION AND A 4-OXO-BUTANOIC ACID AND ITS USE FOR TREATING DIABETES
FR2832925B1 (en) 2001-12-03 2006-07-14 Lipha USE OF 4-OXOBUTANOIC ACID DERIVATIVES IN THE TREATMENT OF INFLAMMATION
FR2834214B1 (en) * 2001-12-28 2004-09-24 Lipha PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND 4-OXO-BUTANOIC ACID AND ITS USE FOR TREATING DIABETES
FR2834640B1 (en) * 2002-01-11 2004-09-24 Lipha PHARMACEUTICAL COMPOSITION COMPRISING A GLITAZONE AND A 4-OXOBUTANOIC ACID AND ITS USE FOR TREATING DIABETES
CA2502297C (en) * 2002-11-01 2011-12-13 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
ATE468114T1 (en) * 2002-11-08 2010-06-15 High Point Pharmaceuticals Llc SAFE CHEMICAL UNCOUPLERS FOR TREATING OBESITY
FR2849598B1 (en) * 2003-01-07 2006-09-22 Merck Sante Sas USE OF KYNURENINE-3-HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES BY INCREASING THE NUMBER OF CELLS OF THE LANGERHANS ISLANDS
FR2849599B1 (en) * 2003-01-07 2006-12-29 Merck Sante Sas USE OF KYNURENINE-3-HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES
CN1774244A (en) * 2003-04-15 2006-05-17 维尔斯达医疗公司 Compounds for the treatment of metabolic disorders
ES2368692T3 (en) 2007-12-03 2011-11-21 Merck Patent Gmbh USE OF 4-OXOBUTANOIC ACID DERIVATIVES IN THE TREATMENT OF ASSOCIATED PATHOLOGIES WITH IMMUNE DISORDERS.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190340B (en) * 1986-06-06 1988-02-16 Roussel Maestretti Spa DERIVATIVES OF 4-FENYL 4-BONE 2-BUTENOIC ACID, THEIR PREPARATION PROCEDURE AND THEIR USE AS MEDICINAL PRODUCTS
DK523288A (en) * 1987-10-06 1989-04-07 Hoffmann La Roche AMINO ACID DERIVATIVES
US5250517A (en) * 1987-10-06 1993-10-05 Hoffmann-La Roche Inc. Renin inhibiting compounds
CA1329680C (en) * 1987-11-23 1994-05-17 Harold Norris Weller, Iii N-heterocyclic alcohol derivatives
US5055466A (en) * 1987-11-23 1991-10-08 E. R. Squibb & Sons, Inc. N-morpholino derivatives and their use as anti-hypertensive agents
FR2733750B1 (en) 1995-05-03 1997-06-13 Synthelabo DERIVATIVES OF GAMMA-OXO-ALPHA- (PHENYLMETHYL) -5,6- DIHYDRO-4H-THIENO (3,4-C) PYRROLE-5-BUTANOIQUE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
TW438764B (en) 2001-06-07
TR199900329T2 (en) 1999-04-21
SK283055B6 (en) 2003-02-04
DE69708130T2 (en) 2002-06-20
SK18099A3 (en) 2000-03-13
CZ294165B6 (en) 2004-10-13
PL187371B1 (en) 2004-06-30
UA57031C2 (en) 2003-06-16
DK0925273T3 (en) 2002-02-18
RU2175966C2 (en) 2001-11-20
PT925273E (en) 2002-04-29
KR100488430B1 (en) 2005-05-10
DE69708130D1 (en) 2001-12-13
CA2263348A1 (en) 1998-02-26
CY2298B1 (en) 2003-07-04
CA2263348C (en) 2008-05-13
ATE208364T1 (en) 2001-11-15
PL331645A1 (en) 1999-08-02
NO990707D0 (en) 1999-02-15
NO990707L (en) 1999-02-15
JP2000506543A (en) 2000-05-30
FR2752422B1 (en) 1998-11-06
HUP0004223A2 (en) 2001-04-28
US6143787A (en) 2000-11-07
CN1227538A (en) 1999-09-01
ZA977327B (en) 1998-03-30
HUP0004223A3 (en) 2001-12-28
WO1998007681A1 (en) 1998-02-26
CZ49899A3 (en) 1999-05-12
JP3105545B2 (en) 2000-11-06
EP0925273B1 (en) 2001-11-07
SI0925273T1 (en) 2002-04-30
AR009251A1 (en) 2000-04-12
AU725440B2 (en) 2000-10-12
EP0925273A1 (en) 1999-06-30
NO312290B1 (en) 2002-04-22
CN1082370C (en) 2002-04-10
KR20000068106A (en) 2000-11-25
ES2166098T3 (en) 2002-04-01
BR9711315A (en) 1999-08-17
HK1021728A1 (en) 2000-06-30
FR2752422A1 (en) 1998-02-20
AU3942297A (en) 1998-03-06

Similar Documents

Publication Publication Date Title
ID20807A (en) SULFONILAMINOKARBOKSILAT ACID
ID20809A (en) SUBSTITUTED DIAMINOCARBOXICATE ACID
ID24686A (en) AMINO ACID BIOSINETIC PLANTS
FI20071025L (en) Pharmaceutical compositions
NO20004345D0 (en) Pharmaceutical composition
ID18352A (en) PHARMACEUTICAL COMPOSITIONS
FI991302A7 (en) Improved pharmaceutical compositions
ID22053A (en) AMINOFOSFONATE ACID DURATION IN PHARMACEUTICAL PROPERTIES
ID24596A (en) PHARMACEUTICAL MICROSPHERE WHICH CONTAIN VALPROAT ACID FOR ORAL USAGE
ID18712A (en) 4-BIFENYL-4-HYDROXYBUTIRATE ACIDED SUBSTANCES AS METALOPROTEASE MATRIERS
ID17875A (en) PHARMACEUTICAL COMPOSITION THAT CONTAINS 4-OXSOBUTANOIC ACID
EE9800400A (en) Pharmaceutical compositions containing diclofenac
BR9507768A (en) Pharmaceutical composition
FI973229A7 (en) New pharmaceutical composition
LV11727A (en) Pharmaceutical composition
ID18698A (en) PHARMACEUTICAL COMPOSITION
ID25857A (en) PHARMACEUTICAL COMPOSITION
ID27729A (en) ANTI-ENZYM COMPOSITION THAT CONTAINS ACIDICINATE ACID
ITMI942166A0 (en) PHARMACEUTICAL COMPOSITIONS MIORELAXANTS
FI973280L (en) Pharmaceutical composition
ID21355A (en) MAKING ADIPAT ACID
FI961364L (en) Drug composition
ID22212A (en) HYDROXIC ACID PLANTATIONS
ITMI962628A0 (en) PHARMACEUTICAL COMPOSITION
FI962738A7 (en) Pharmaceutical compositions